{"entity":{"type":"insider","cik":"0001652996","url":"/insider/0001652996","json_url":"/insider/0001652996.json","name":"Cullen Michael T.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2016-06-28","last":"2022-10-06","span_basis":"filed_date"},"name_variants":[{"name":"Cullen Michael T.","source":"filing","n_filings":7,"first_seen":"2016-06-28","last_seen":"2022-10-06"}],"transactions":[{"id":6949078,"accession":"0001437749-22-023776","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-023776","line_url":"/filing/0001437749-22-023776#line-1","is_derivative":false,"issuer_cik":"0001029125","issuer_name":"Panbela Therapeutics, Inc.","issuer_ticker":"PBLA","issuer_name_source":null,"issuer_url":"/issuer/0001029125","owner_cik":"0001652996","owner_name":"Cullen Michael T.","owner_display_name":"Cullen Michael T.","owner_url":"/insider/0001652996","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":165000.0,"shares_display":"165,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":369576.0,"shares_owned_after_display":"369,576","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-06","scope":"insider"},{"id":2094039,"accession":"0001437749-20-019142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-019142","line_url":"/filing/0001437749-20-019142#line-1","is_derivative":false,"issuer_cik":"0001029125","issuer_name":"Sun BioPharma, Inc.","issuer_ticker":"SNBP","issuer_name_source":null,"issuer_url":"/issuer/0001029125","owner_cik":"0001652996","owner_name":"Cullen Michael T.","owner_display_name":"Cullen Michael T.","owner_url":"/insider/0001652996","role":"Director, Officer (Exec. Chairman, Pres. & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. Chairman, Pres. & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":207995.0,"shares_owned_after_display":"207,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-01","scope":"insider"},{"id":9288216,"accession":"0001437749-20-019141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-019141","line_url":"/filing/0001437749-20-019141#line-1","is_derivative":false,"issuer_cik":"0001029125","issuer_name":"Sun BioPharma, Inc.","issuer_ticker":"SNBP","issuer_name_source":null,"issuer_url":"/issuer/0001029125","owner_cik":"0001652996","owner_name":"Cullen Michael T.","owner_display_name":"Cullen Michael T.","owner_url":"/insider/0001652996","role":"Director, Officer (Exec. Chairman, Pres. & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. Chairman, Pres. & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":204576.0,"shares_owned_after_display":"204,576","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-22","filed_date":"2020-09-01","scope":"insider"},{"id":2812750,"accession":"0001437749-20-011818","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-011818","line_url":"/filing/0001437749-20-011818#line-1","is_derivative":false,"issuer_cik":"0001029125","issuer_name":"Sun BioPharma, Inc.","issuer_ticker":"SNBP","issuer_name_source":null,"issuer_url":"/issuer/0001029125","owner_cik":"0001652996","owner_name":"Cullen Michael T.","owner_display_name":"Cullen Michael T.","owner_url":"/insider/0001652996","role":"Director, Officer (Exec. Chairman, Pres. & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. Chairman, Pres. & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":207995.0,"shares_owned_after_display":"207,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-22","filed_date":"2020-05-27","scope":"insider"},{"id":8766643,"accession":"0001437749-19-017893","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-017893","line_url":"/filing/0001437749-19-017893#line-1","is_derivative":false,"issuer_cik":"0001029125","issuer_name":"Sun BioPharma, Inc.","issuer_ticker":"SNBP","issuer_name_source":null,"issuer_url":"/issuer/0001029125","owner_cik":"0001652996","owner_name":"Cullen Michael T.","owner_display_name":"Cullen Michael T.","owner_url":"/insider/0001652996","role":"Director, Officer (Exec. Chairman, Pres. & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. Chairman, Pres. & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":197995.0,"shares_owned_after_display":"197,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-30","filed_date":"2019-09-04","scope":"insider"},{"id":6591340,"accession":"0001437749-18-003135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-18-003135","line_url":"/filing/0001437749-18-003135#line-1","is_derivative":false,"issuer_cik":"0001029125","issuer_name":"Sun BioPharma, Inc.","issuer_ticker":"SNBP","issuer_name_source":null,"issuer_url":"/issuer/0001029125","owner_cik":"0001652996","owner_name":"Cullen Michael T.","owner_display_name":"Cullen Michael T.","owner_url":"/insider/0001652996","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":194576.0,"shares_owned_after_display":"194,576","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-20","filed_date":"2018-02-22","scope":"insider"},{"id":2717531,"accession":"0001437749-16-034504","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-16-034504","line_url":"/filing/0001437749-16-034504#line-1","is_derivative":false,"issuer_cik":"0001029125","issuer_name":"Sun BioPharma, Inc.","issuer_ticker":"SNBP","issuer_name_source":null,"issuer_url":"/issuer/0001029125","owner_cik":"0001652996","owner_name":"Cullen Michael T.","owner_display_name":"Cullen Michael T.","owner_url":"/insider/0001652996","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":1895764.0,"shares_owned_after_display":"1,895,764","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-24","filed_date":"2016-06-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001029125","name":"Panbela Therapeutics, Inc.","url":"/issuer/0001029125","role":"Director, Officer (Exec. Chairman, Pres. & CEO), Ten percent owner","n_filings":7,"first_seen":"2016-06-28","last_seen":"2022-10-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001652996","retrieved_at":"2026-08-25T07:24:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}